| Quantitative evaluation of expression of iron-metabolism genes in ceruloplasmin-deficient mice. Yamamoto K., Yoshida K., Miyagoe Y., Ishikawa A., Hanaoka K., Nomoto S., Kaneko K., Ikeda S., Takeda S.
Biochim. Biophys. Acta 1588:195-202(2002) · Mapped (11) |
| Interaction of merosin (laminin 2) with very late activation antigen-6 is necessary for the survival of CD4+ CD8+ immature thymocytes. Iwao M., Fukada S., Harada T., Tsujikawa K., Yagita H., Hiramine C., Miyagoe Y., Takeda S., Yamamoto H.
Immunology 99:481-488(2000) · Mapped (6) |
| alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. Kameya S., Miyagoe Y., Nonaka I., Ikemoto T., Endo M., Hanaoka K., Nabeshima Y., Takeda S.
J. Biol. Chem. 274:2193-2200(1999) · Mapped (5) |
| Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. Miyagoe Y., Hanaoka K., Nonaka I., Hayasaka M., Nabeshima Y., Arahata K., Nabeshima Y., Takeda S.
FEBS Lett. 415:33-39(1997) · Mapped (6) |
| Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. Kitamura D., Kaneko H., Miyagoe Y., Ariyasu T., Watanabe T.
Nucleic Acids Res. 17:9367-9379(1989) · UniProtKB (1) |
